A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

NCT01478607 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Painful Diabetic Peripheral Neuropathy (PDPN)

Interventions

DRUG: QUTENZA

Sponsor

Astellas Pharma Inc